https://www.googletagmanager.com/gtag/js?id=UA-12246292-10

Photos of the Santiago Medina Sculpture

Thank you to Dr. Santiago Medina for the creation of the Santiago Medina sculpture presented to the recipient of The Foundation of the ASNR “Outstanding Contributions in Research Award”

2020 Outstanding Contributions in Research Award Recipient

Mayank Goyal, MD, PhD, FRCPC

University of Calgary, Canada

Mayank Goyal is a Professor in the Department of Radiology and Clinical Neurosciences at the University of Calgary. He is the Director of Imaging and Endovascular treatment at the Calgary Stroke Program.

Mayank did his medical training and residency at the All India Institute of Medical Sciences, New Delhi, India. He did his fellowship in Neuroradiology at the University of Toronto and his PhD at Erasmus University, Rotterdam, Netherlands.

Dr. Goyal’s passion and main research interest is acute stroke imaging, workflow and intervention. He has over 200 publications in peer-reviewed journals including first/senior author publications in NEJM, Lancet, JAMA, and Lancet Neurology. He was one of the Principal Investigators in two global multi-centric trials in the field: ESCAPE and SWIFT PRIME (both published in NEJM). He was also the core-lab for the REVASCAT trial (published in NEJM). He was the Co-PI of a CIHR funded study called PROVE IT. Mayank is also the Co-PI of the recently concluded ESCAPE-NA1 trial that is testing a novel neuroprotectant in acute stroke patients undergoing endovascular thrombectomy. He recently led two worldwide studies (UNMASK-EVT and ESCAPE- ALICE) across over 50 countries on physician decision making in patients with acute stroke and other neurointerventional procedures.

Dr. Goyal is world renowned for his ground-breaking work in efficiency and workflow in acute stroke intervention. In addition, Mayank is an innovator and is always thinking of novel solutions to day-to-day problems. He came up with a new way of imaging in acute stroke called multiphase CT angiography (patented). As a consequence he was awarded the Innovator of the Year award for 2018 by Alberta Science and Technology and by the Society of Vascular and Intervention Neurology. This technique subsequently became the basis for the PROVE IT study (which is study doing a head to head comparison between multiphase CTA and CT perfusion) and was implemented globally as part of the ESCAPE trial and subsequently the ESCAPE-NA1 trial. Initial results and feedback suggest that the technique is extremely useful and saves on average 20 minutes in acute stroke treatment (published in Radiology).

With the success of ESCAPE and SWIFT PRIME, Dr. Goyal has been an integral part of changing stroke care across the world and helping thousands of patients have a good outcome from what is otherwise a devastating disease.  He currently collaborates and has co-authored publications with colleagues from more than 250 researchers from over 20 countries. He is also leading a worldwide collaboration (HERMES) consisting of the leadership of the recent 7 positive trials for endovascular thrombectomy. The first paper (Mayank as first author) showing benefit across all sub-groups was published in Lancet. The second paper analyzing the impact of time on outcome was published in JAMA (Mayank as co-first author). Mayank enjoys teaching and successfully runs a yearly stroke course called 5T (where the 5Ts stand for: teamwork, transport, training, technique, and technology).

Dr. Goyal is a long-standing member of ASNR, RSNA, and SNIS. He recently received a career achievement award from the Canadian Association of Radiology. He is also a Fellow of the Canadian Academy of Health Sciences, European Stroke Association and American Heart Association. In 2019, Mayank was in the top 1% list of the most cited scientists from the Web of Science.